🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Icahn Buys More Herbalife (HLF) Shares After 2.3M Stake Buy

Published 09/05/2016, 07:38 AM
Updated 07/09/2023, 06:31 AM
AVP
-
NUS
-
USNA
-
HLF
-

Activist investor, Carl Icahn has purchased another 306,846 shares of Herbalife Ltd. (NYSE:HLF) this week, as per Bloomberg, after adding 2.3 million shares to his portfolio last week. Shares of this nutrition-supplements company gained 0.29% on Friday, after Icahn paid $60.39 a share for the added stake on Aug 31.

Last week, Icahn acquired an additional 2.3 million Herbalife shares, after billionaire activist investor Bill Ackman reportedly stated that Icahn was looking to sell his stake in the company.

Hedge fund manager, Bill Ackman reportedly stated to CNBC early on Aug 26 that Icahn considered selling his stake in Herbalife, worth approximately $1 billion, to a consortium that included Ackman.

According to sources, Ackman said that Icahn was interested in selling off his stake and was therefore looking for buyers, in anticipation of good returns.

Icahn, however, stated that he never directly put in a sell order. In fact, he hit back harder at Ackman by buying more stake in the firm, thus signaling his loyalty toward the company.

HERBALIFE LTD Price and Consensus

HERBALIFE LTD Price and Consensus | HERBALIFE LTD Quote

Icahn and Ackman have been battling over Herbalife for years. Icahn's position in Herbalife is worth more than a billion dollars, shares which he started accumulating in late 2012. Ackman, on the other hand, took a short position in the company in late 2012. He claimed that the company is running a pyramid scheme, which involves making money by way of recruiting more salespeople rather than selling products. Such models are illegal because they eventually collapse once there are no more people to recruit.

Herbalife, on its part, has been denying the charges from the very beginning. The company clarified that it operates like a multi-level marketing company, similar to Nu Skin Enterprises Inc. (NYSE:NUS) , USANA Health Sciences Inc. (NYSE:USNA) and Avon Products Inc. (NYSE:AVP) .

However, Ackman's back-to-back allegations prompted a civil investigative demand in 2014 by the U.S. Federal Trade Commission (“FTC”) related to the company’s marketing practices. Nevertheless, in mid-July, Herbalife reached a settlement with the FTC, and agreed to pay $200 million as penalty charges. The FTC had charged that Herbalife's earnings potential claims were deceptive and its compensation structure hinged on recruiting other product distributors instead of selling capability.

Nevertheless, Herbalife has remained upbeat about its prospects. The company reported better-than-expected second-quarter 2016 results on the back of higher sales and improving volume trends. Management also raised its view for full-year 2016.

Herbalife currently carries a Zacks Rank #2 (Buy).

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



AVON PRODS INC (AVP): Free Stock Analysis Report

NU SKIN ENTERP (NUS): Free Stock Analysis Report

USANA HLTH SCI (USNA): Free Stock Analysis Report

HERBALIFE LTD (HLF): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.